morpholinoanthracycline mx2 has been researched along with sq-23377 in 1 studies
| Studies (morpholinoanthracycline mx2) | Trials (morpholinoanthracycline mx2) | Recent Studies (post-2010) (morpholinoanthracycline mx2) | Studies (sq-23377) | Trials (sq-23377) | Recent Studies (post-2010) (sq-23377) |
|---|---|---|---|---|---|
| 53 | 15 | 0 | 4,385 | 10 | 493 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adachi, M; Date, M; Fukuhara, S; Katsurada, T; Kido, H; Kimura, T; Kishimoto, Y; Yamanaka, Y | 1 |
1 other study(ies) available for morpholinoanthracycline mx2 and sq-23377
| Article | Year |
|---|---|
Induction of apoptosis in megakaryocytic leukemia cell lines by MX2, a morpholino anthracycline.
Topics: Antibiotics, Antineoplastic; Apoptosis; Benzoquinones; Carubicin; DNA Fragmentation; Enzyme Inhibitors; Humans; Ionomycin; Lactams, Macrocyclic; Leukemia, Megakaryoblastic, Acute; Megakaryocytes; Microscopy, Electron; Protein-Tyrosine Kinases; Quinones; Rifabutin; Staurosporine; Tumor Cells, Cultured | 1997 |